Company Filing History:
Years Active: 2006
Title: Lucie Srsnová: Innovator in Antidiabetic Research
Introduction
Lucie Srsnová is a notable inventor based in Chrudim, Czech Republic. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antidiabetic agents. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to improving healthcare solutions.
Latest Patents
Lucie Srsnová holds a patent for a method of obtaining pioglitazone, an antidiabetic agent. The patent describes a comprehensive method that involves the condensation of a 4-derivatized phenol or phenolate, which is crucial for synthesizing pioglitazone. This method includes several steps, such as diazotizing the amino group, converting the diazotized residue into a derivative, cyclizing with thiourea, and hydrolyzing the resulting imine to yield pioglitazone.
Career Highlights
Lucie Srsnová is currently employed at Zentiva, a prominent pharmaceutical company. Her work at Zentiva has allowed her to focus on innovative drug development, particularly in the area of diabetes treatment. With her patent, she has demonstrated her ability to contribute to significant advancements in medical science.
Collaborations
Lucie has collaborated with esteemed colleagues, including Ales Halama and Ludmila Hejtmánková. These collaborations have fostered a productive environment for research and innovation, enhancing the quality of their work in the pharmaceutical field.
Conclusion
Lucie Srsnová is a pioneering inventor whose work in antidiabetic research has made a meaningful impact on healthcare. Her patent for the method of obtaining pioglitazone exemplifies her commitment to advancing medical treatments.